Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial ; volume:25 ; number:1 ; day:13 ; month:11 ; year:2013 ; pages:385-392 ; date:1.2014
Osteoporosis international ; 25, Heft 1 (13.11.2013), 385-392, 1.2014
- Urheber
-
Klop, C.
Vries, F. de
Vinks, T.
Kooij, M. J.
Staa, T. P. van
Bijlsma, J. W. J.
Egberts, A. C. G.
Bouvy, M. L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-013-2562-8
- URN
-
urn:nbn:de:101:1-2019101707131274104748
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klop, C.
- Vries, F. de
- Vinks, T.
- Kooij, M. J.
- Staa, T. P. van
- Bijlsma, J. W. J.
- Egberts, A. C. G.
- Bouvy, M. L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Osteoporosis prophylaxis in acute SCI
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacist interventions in osteoporosis management: a systematic review
Zerebrales Glucocorticoid-Feedback bei metabolischen Erkrankungen
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Osteoporosis prophylaxis in acute SCI
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacist interventions in osteoporosis management: a systematic review
Zerebrales Glucocorticoid-Feedback bei metabolischen Erkrankungen
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis
Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis
Glucocorticoid induced osteoporosis : 12 tables
Glucocorticoid-induced osteoporosis: an update
Osteoporosis prophylaxis in acute SCI
Linking glucocorticoid-induced osteoporosis to osteoimmunology
Pharmacist interventions in osteoporosis management: a systematic review
Zerebrales Glucocorticoid-Feedback bei metabolischen Erkrankungen
Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
The critical role of T cells in glucocorticoid-induced osteoporosis
Intramembranous ossification and endochondral ossification are impaired differently between glucocorticoid-induced osteoporosis and estrogen deficiency-induced osteoporosis
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis